The fellow eye effect - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Impact of Ocular Conditions on the Contralateral Eye

  • By

  • Hashem Abu Serhan

  • May 7, 2026

Share

Objective:

To explore the bilateral tendencies of ocular conditions, specifically the 'fellow eye effect', and its implications for treatment.

Key Findings:
  • Sympathetic ophthalmia exemplifies the immune-mediated fellow eye effect, highlighting the need for bilateral monitoring.
  • Unilateral glaucoma can increase the risk of contralateral glaucoma due to bilateral susceptibility, necessitating proactive management.
  • Intravitreal anti-VEGF treatments can improve the untreated eye's condition, demonstrating the systemic effects of localized treatment.
  • Surgical interventions may lead to changes in intraocular pressure in the fellow eye, indicating the interconnectedness of ocular health.
  • Neuro-ophthalmologic interactions illustrate the dynamic nature of bilateral visual processing, affecting treatment outcomes.
Interpretation:

The fellow eye effect underscores the interconnectedness of ocular health, necessitating comprehensive monitoring and treatment strategies for both eyes.

Limitations:
  • Variability in responses to treatments and interventions, influenced by individual patient factors.
  • Incomplete understanding of underlying mechanisms, which may affect treatment efficacy.
  • Potential confounding factors such as patient behavior, adherence, and systemic health conditions.
Conclusion:

Recognizing the fellow eye effect is crucial for effective management of ocular diseases, emphasizing the need for bilateral consideration in treatment strategies.

Original Source(s)

The fellow eye effect

  • by Hashem Abu Serhan

  • May 7, 2026

Related Content

A Novel Technique for Uveitis

Dr. David Chin Yee describes the benefits of delivering XIPERE directly into the suprachoroidal space

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.